SI2468274T1 - Transdermalni terapevtski sistem za dajanje aktivne snovi - Google Patents

Transdermalni terapevtski sistem za dajanje aktivne snovi

Info

Publication number: SI2468274T1
Authority: SI; Slovenia
Prior art keywords: agent; application; therapeutic system; transdermal therapeutic; transdermal
Prior art date: 2010-12-14

Application number

SI201031006T

Other languages

English (en)

Inventor

Britta Schroder

Bjorn Schurad

Heike Hausner

Original Assignee

Acino Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2010-12-14

Filing date

2010-12-14

Publication date

2015-10-30

2010-12-14 Application filed by Acino Ag filed Critical Acino Ag

2015-10-30 Publication of SI2468274T1 publication Critical patent/SI2468274T1/sl

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/27—Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Epidemiology (AREA)
Dermatology (AREA)
Emergency Medicine (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Psychiatry (AREA)
Hospice & Palliative Care (AREA)
Inorganic Chemistry (AREA)
Psychology (AREA)
Medicinal Preparation (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

SI201031006T 2010-12-14 2010-12-14 Transdermalni terapevtski sistem za dajanje aktivne snovi SI2468274T1 (sl)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
EP10194968.3A EP2468274B1 (de)	2010-12-14	2010-12-14	Transdermales therapeutisches System zur Verabreichung eines Wirkstoffs

Publications (1)

Publication Number	Publication Date
SI2468274T1 true SI2468274T1 (sl)	2015-10-30

Family

ID=43836835

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
SI201031006T SI2468274T1 (sl)	2010-12-14	2010-12-14	Transdermalni terapevtski sistem za dajanje aktivne snovi
SI201131933T SI2651410T1 (sl)	2010-12-14	2011-12-14	Transdermalni terapevtski sistem za dajanje aktivne snovi

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
SI201131933T SI2651410T1 (sl)	2010-12-14	2011-12-14	Transdermalni terapevtski sistem za dajanje aktivne snovi

Country Status (25)

Country	Link
US (2)	US10660863B2 (sl)
EP (2)	EP2468274B1 (sl)
JP (1)	JP6043296B2 (sl)
KR (1)	KR101842309B1 (sl)
CN (3)	CN107412202A (sl)
AU (2)	AU2011343363B2 (sl)
BR (1)	BR112013014616B1 (sl)
CA (2)	CA2817461C (sl)
CY (2)	CY1116638T1 (sl)
DK (2)	DK2468274T3 (sl)
EA (1)	EA026520B1 (sl)
ES (2)	ES2545094T3 (sl)
HK (1)	HK1243336A1 (sl)
HR (2)	HRP20201880T1 (sl)
HU (2)	HUE027916T2 (sl)
LT (1)	LT2651410T (sl)
MX (1)	MX345344B (sl)
MY (1)	MY183873A (sl)
PL (2)	PL2468274T3 (sl)
PT (2)	PT2468274E (sl)
RS (2)	RS54173B1 (sl)
SI (2)	SI2468274T1 (sl)
SM (2)	SMT202000638T1 (sl)
WO (1)	WO2012080365A1 (sl)
ZA (1)	ZA201303965B (sl)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE102012000369A1 (de) *	2012-01-11	2013-07-11	Alfred E. Tiefenbacher (Gmbh & Co. Kg)	Transdermales therapeutisches System mit Cholinesterase-Hemmer
DE102012016317A1 (de)	2012-08-14	2014-02-20	Jenabatteries GmbH	Redox-Flow-Zelle zur Speicherung elektrischer Energie
US20150196515A1 (en) *	2012-08-15	2015-07-16	Dow Coming Corporation	Multi-Layer Drug Delivery System
WO2014111790A2 (en) *	2013-01-15	2014-07-24	Zydus Technologies Limited	Stable transdermal pharmaceutical drug delivery system comprising rivastigmine
US20240082065A1 (en) *	2016-07-08	2024-03-14	Moteah Williams	Waterproof and transparent wound barrier and method of manufacturing same
CN109640976B (zh)	2016-08-22	2023-10-17	救急药品工业株式会社	贴附剂
WO2019017266A1 (ja) *	2017-07-19	2019-01-24	帝國製薬株式会社	リバスチグミン含有経皮吸収型製剤
DE102018120506A1 (de) *	2017-10-20	2019-04-25	Amw Gmbh	Stabilisiertes transdermales Darreichungssystem
DE102017127433A1 (de) *	2017-11-21	2019-05-23	Lts Lohmann Therapie-Systeme Ag	TTS auf Basis von klebenden Weichmacher-Polymer-Matrices
CN111971032A (zh) *	2018-03-13	2020-11-20	罗曼治疗系统股份公司	包含有机硅丙烯酸杂化聚合物的透皮治疗系统
JP7170285B2 (ja) *	2018-05-17	2022-11-14	パナソニックＩｐマネジメント株式会社	生体貼付け用選択透過膜、経皮吸収キットおよび美容方法
EP3871877A1 (en)	2018-08-08	2021-09-01	Danapak Flexibles A/S	Improved films and laminates for use in packaging reactive compounds
KR102823139B1 (ko)	2018-08-31	2025-06-19	에스케이케미칼 주식회사	장기 투여용 리바스티그민 패취
KR102710072B1 (ko)	2018-08-31	2024-09-24	에스케이케미칼 주식회사	장기 투여용 리바스티그민 패취
EP3996693A1 (en) *	2019-07-09	2022-05-18	LTS Lohmann Therapie-Systeme AG	Transdermal therapeutic system comprising an active agent-containing layer comprising an acrylic polymer and a skin contact layer comprising a silicone gel adhesive
CN113616625B (zh) *	2021-08-26	2023-05-30	大连科翔科技开发有限公司	一种卡巴拉汀的长效透皮贴剂
DE102021128912A1 (de) *	2021-11-05	2023-05-11	Lts Lohmann Therapie-Systeme Ag.	Okklusives pflaster mit flexibler backing

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
HU201906B (en)	1987-03-04	1991-01-28	Sandoz Ag	Process for producing phenyl-carbamate derivative and acid additional salts and pharmaceutical compositions containing them
KR950702811A (ko) *	1992-08-25	1995-08-23	더블유. 클레어리 게리	프린트 경피약제투여장치(Printed Transdermal Drug Delivery Device)
JPH0912448A (ja) *	1995-04-28	1997-01-14	Read Chem Kk	薬物放出制御型経皮吸収製剤
GB9800526D0 (en) *	1998-01-12	1998-03-11	Ciba Geigy Ag	Organic compounds
US6348210B1 (en) *	1998-11-13	2002-02-19	Alza Corporation	Methods for transdermal drug administration
DE19918106A1 (de)	1999-04-22	2000-10-26	Lohmann Therapie Syst Lts	Transdermales therapeutisches System mit neutralisierten Acrylathaftklebern
DE10033853A1 (de)	2000-07-12	2002-01-31	Hexal Ag	Transdermales therapeutisches System mit hochdispersem Siliziumdioxid
DE10103860B4 (de) *	2001-01-30	2004-12-23	Lts Lohmann Therapie-Systeme Ag	Transdermales therapeutisches System für die Verabreichung carboxylgruppenhaltiger, nichtsteroidaler Antiphlogistika, sowie Verfahren zu seiner Herstellung
DE10141652B4 (de)	2001-08-24	2011-04-07	Lts Lohmann Therapie-Systeme Ag	Transdermales therapeutisches System auf der Basis von Polyacrylat-Haftklebern ohne funktionelle Gruppen und seine Verwendung
DE10141650C1 (de) *	2001-08-24	2002-11-28	Lohmann Therapie Syst Lts	Transdermales Therapeutisches System mit Fentanyl bzw. verwandten Substanzen
US8252320B2 (en)	2004-10-21	2012-08-28	Durect Corporation	Transdermal delivery system for sufentanil
ES2385386T3 (es) *	2004-10-21	2012-07-24	Durect Corporation	Sistemas de administración transdérmica
TWI389709B (zh) *	2005-12-01	2013-03-21	Novartis Ag	經皮治療系統
CN101351233A (zh) *	2005-12-30	2009-01-21	科洛普拉斯特公司	具有可塑的层作为皮肤接触表面的层状粘合构造
CN101304735A (zh) *	2006-01-12	2008-11-12	Lts勒曼治疗系统股份公司	用于挥发性和/或热不稳定的物质的经皮治疗体系
JP5122445B2 (ja)	2006-05-08	2013-01-16	帝國製薬株式会社	抗認知症薬物の経皮吸収製剤
US9248104B2 (en) *	2006-08-17	2016-02-02	Core Tech Solutions, Inc.	Transdermal methods and systems for treating Alzheimer's disease
DE102006054731B4 (de) *	2006-11-21	2013-02-28	Lts Lohmann Therapie-Systeme Ag	Transdermales therapeutisches System zur Verabreichung des Wirkstoffs Buprenorphin und Verwendung desselben in der Schmerztherapie
US20100292660A1 (en)	2007-07-10	2010-11-18	Agis Kydonieus	Dermal delivery device with ultrasonic weld
WO2009026135A2 (en) *	2007-08-17	2009-02-26	Alza Corporation	Controlled transdermal bisoprolol delivery system
US9155725B2 (en) *	2008-02-27	2015-10-13	Hisamitsu Pharmaceutical Co., Inc.	Adhesive skin patch and packaged product
US20090291127A1 (en) *	2008-05-21	2009-11-26	Jianye Wen	Transdermal anti-dementia active agent formulations and methods for using the same
JP2010126450A (ja) *	2008-11-25	2010-06-10	Lintec Corp	経皮吸収貼付剤
MX350357B (es) *	2009-12-22	2017-09-05	Luye Pharma Ag	Sistema terapeutico transdermico para administrar rivastigmina o derivados de este.

2010
- 2010-12-14 ES ES10194968.3T patent/ES2545094T3/es active Active
- 2010-12-14 PT PT101949683T patent/PT2468274E/pt unknown
- 2010-12-14 RS RS20150562A patent/RS54173B1/sr unknown
- 2010-12-14 HU HUE10194968A patent/HUE027916T2/en unknown
- 2010-12-14 PL PL10194968T patent/PL2468274T3/pl unknown
- 2010-12-14 DK DK10194968.3T patent/DK2468274T3/en active
- 2010-12-14 SI SI201031006T patent/SI2468274T1/sl unknown
- 2010-12-14 EP EP10194968.3A patent/EP2468274B1/de active Active
2011
- 2011-12-14 CA CA2817461A patent/CA2817461C/en active Active
- 2011-12-14 JP JP2013543774A patent/JP6043296B2/ja active Active
- 2011-12-14 CA CA3065240A patent/CA3065240C/en active Active
- 2011-12-14 AU AU2011343363A patent/AU2011343363B2/en active Active
- 2011-12-14 ES ES11799413T patent/ES2836483T3/es active Active
- 2011-12-14 HR HRP20201880TT patent/HRP20201880T1/hr unknown
- 2011-12-14 WO PCT/EP2011/072812 patent/WO2012080365A1/de not_active Ceased
- 2011-12-14 CN CN201710451001.1A patent/CN107412202A/zh active Pending
- 2011-12-14 SI SI201131933T patent/SI2651410T1/sl unknown
- 2011-12-14 HU HUE11799413A patent/HUE052137T2/hu unknown
- 2011-12-14 CN CN201180059614.1A patent/CN103269698B/zh active Active
- 2011-12-14 MY MYPI2013001975A patent/MY183873A/en unknown
- 2011-12-14 BR BR112013014616-8A patent/BR112013014616B1/pt active IP Right Grant
- 2011-12-14 EA EA201300704A patent/EA026520B1/ru not_active IP Right Cessation
- 2011-12-14 US US13/994,242 patent/US10660863B2/en active Active
- 2011-12-14 LT LTEP11799413.7T patent/LT2651410T/lt unknown
- 2011-12-14 CN CN202110438860.3A patent/CN113244199A/zh active Pending
- 2011-12-14 PT PT117994137T patent/PT2651410T/pt unknown
- 2011-12-14 PL PL11799413T patent/PL2651410T3/pl unknown
- 2011-12-14 EP EP11799413.7A patent/EP2651410B1/de active Active
- 2011-12-14 KR KR1020137016047A patent/KR101842309B1/ko active Active
- 2011-12-14 DK DK11799413.7T patent/DK2651410T3/da active
- 2011-12-14 RS RS20201478A patent/RS61155B1/sr unknown
- 2011-12-14 MX MX2013005581A patent/MX345344B/es active IP Right Grant
- 2011-12-14 SM SM20200638T patent/SMT202000638T1/it unknown
2013
- 2013-05-30 ZA ZA2013/03965A patent/ZA201303965B/en unknown
2015
- 2015-07-31 SM SM201500184T patent/SMT201500184B/xx unknown
- 2015-08-19 HR HRP20150881TT patent/HRP20150881T1/hr unknown
- 2015-08-25 CY CY20151100738T patent/CY1116638T1/el unknown
2017
- 2017-08-11 AU AU2017213569A patent/AU2017213569B2/en active Active
2018
- 2018-02-28 HK HK18102858.7A patent/HK1243336A1/zh unknown
2020
- 2020-04-28 US US16/860,210 patent/US20200289426A1/en not_active Abandoned
- 2020-11-25 CY CY20201101121T patent/CY1123712T1/el unknown

Also Published As

Publication number	Publication date
AU2017213569A1 (en)	2017-08-31
EP2468274B1 (de)	2015-07-01
RS61155B1 (sr)	2020-12-31
JP2014503523A (ja)	2014-02-13
PL2468274T3 (pl)	2015-11-30
MX2013005581A (es)	2013-08-26
CN113244199A (zh)	2021-08-13
ZA201303965B (en)	2014-09-25
US20200289426A1 (en)	2020-09-17
CY1116638T1 (el)	2017-03-15
HRP20201880T1 (hr)	2021-02-05
HK1243336A1 (zh)	2018-07-13
US20140323996A1 (en)	2014-10-30
KR20130129988A (ko)	2013-11-29
CA3065240C (en)	2022-02-15
LT2651410T (lt)	2020-12-28
CY1123712T1 (el)	2022-03-24
SMT202000638T1 (it)	2021-01-05
EP2651410B1 (de)	2020-10-14
EA201300704A1 (ru)	2014-01-30
CA2817461C (en)	2020-02-25
MY183873A (en)	2021-03-17
HRP20150881T1 (hr)	2015-09-25
PL2651410T3 (pl)	2021-03-08
CN103269698B (zh)	2017-07-14
CN107412202A (zh)	2017-12-01
DK2468274T3 (en)	2015-08-31
KR101842309B1 (ko)	2018-03-26
CA2817461A1 (en)	2012-06-21
AU2011343363B2 (en)	2017-06-08
SMT201500184B (it)	2015-09-07
AU2017213569B2 (en)	2019-04-11
AU2011343363A1 (en)	2013-06-20
US10660863B2 (en)	2020-05-26
EP2651410A1 (de)	2013-10-23
EA026520B1 (ru)	2017-04-28
EP2468274A1 (de)	2012-06-27
DK2651410T3 (da)	2020-11-02
RS54173B1 (sr)	2015-12-31
PT2468274E (pt)	2015-09-21
MX345344B (es)	2017-01-26
PT2651410T (pt)	2020-12-15
BR112013014616A2 (pt)	2016-09-20
JP6043296B2 (ja)	2016-12-14
HUE052137T2 (hu)	2021-04-28
CA3065240A1 (en)	2012-06-21
ES2836483T3 (es)	2021-06-25
WO2012080365A1 (de)	2012-06-21
SI2651410T1 (sl)	2021-01-29
ES2545094T3 (es)	2015-09-08
BR112013014616B1 (pt)	2021-12-21
CN103269698A (zh)	2013-08-28
HUE027916T2 (en)	2016-11-28

Publication	Publication Date	Title
SI2468274T1 (sl)	2015-10-30	Transdermalni terapevtski sistem za dajanje aktivne snovi
HUS2000018I1 (hu)	2020-07-28	Mellékvese hormon-módosító szer alkalmazása
SG10201506840QA (en)	2015-10-29	Cytotoxicity-inducing therapeutic agent
EP2523630A4 (en)	2014-01-08	SYSTEMS AND METHODS FOR BARIATRIC THERAPY
EP2585938A4 (en)	2017-06-21	System for interaction of paired devices
EP2699199A4 (en)	2014-10-29	SYSTEMS AND METHODS FOR BARIATRIC THERAPY
IL222328A (en)	2017-02-28	Tissue microabulation system
ZA201303813B (en)	2015-06-24	Methods of treatment using lipid compounds
GB201016832D0 (en)	2010-11-17	Garment technology for application of therapeutic pressure
ZA201301458B (en)	2014-06-25	Therapeutic agent for pain
IL224381B (en)	2018-03-29	Application of b-functionalized dihydroxy-chlorins for pdt
PL2599487T3 (pl)	2015-09-30	Środek terapeutyczny lub środek profilaktyczny przeciwko bólowi neuropatycznemu
EP2485719A4 (en)	2013-03-27	TRANSDERMAL THERAPEUTIC SYSTEM
PL2456445T3 (pl)	2014-10-31	Środek do leczenia chorób skóry
GB201010638D0 (en)	2010-08-11	Composition for treatment of skin
GB201019938D0 (en)	2011-01-05	Determination of therapeutic agents
GB201009614D0 (en)	2010-07-21	Therapeutic use of compounds
GB201003727D0 (en)	2010-04-21	Therapeutic agent
HK1188741A (en)	2014-05-16	Therapeutic composition for treatment of glioblastoma
TWM402101U (en)	2011-04-21	Structure of body-scraping therapeutic treatment device
HK1182818A (en)	2013-12-06	System for interaction of paired devices
GB201004480D0 (en)	2010-05-05	Therapeutic use of new compounds II
GB201005495D0 (en)	2010-05-19	Compounds for treatment of inflammation
GB201010671D0 (en)	2010-08-11	Compounds for treatment of inflammation